Magic mushroom compound performs at least as well as antidepressant – study

The psychedelic compound found in magic mushrooms may be at least as effective as a leading antidepressant medication in a therapeutic setting, a new study suggests.
Researchers compared the therapeutic potential of psilocybin – found in the mushrooms – with a six-week course of the antidepressant escitalopram in 59 people with moderate to severe depression.
They found that, while depression scores were reduced in both groups, the reductions occurred more quickly in the psilocybin group and were greater in magnitude.
However, they warned that the main comparison between psilocybin and the antidepressant was not statistically significant.
They said larger trials with more patients over a longer period are needed to show if the compound can perform as well as, or more effectively than, an established antidepressant.

Related Keywords

London ,City Of ,United Kingdom ,Anthony Cleare ,Robin Carhart Harris ,David Nutt ,Edmondj Safra ,King College London ,Institute Of Psychiatry Psychology ,Neuropsychopharmacology At Imperial College London ,Psychedelic Research ,Imperial College London ,Edmondj Safra Chair ,New England Journal ,Compass Pathways ,Item Quick Inventory ,Depressive Symptomatology ,Psychiatry Psychology ,College London ,லண்டன் ,நகரம் ஆஃப் ,ஒன்றுபட்டது கிஂக்டம் ,ராபின் கார்ஹார்ட் ஹாரிஸ் ,டேவிட் நட் ,கிங் கல்லூரி லண்டன் ,நிறுவனம் ஆஃப் மனநல மருத்துவம் உளவியல் ,சைகடெலிக் ஆராய்ச்சி ,ஏகாதிபத்தியம் கல்லூரி லண்டன் ,புதியது இங்கிலாந்து இதழ் ,திசைகாட்டி பாதைகள் ,மனநல மருத்துவம் உளவியல் ,கல்லூரி லண்டன் ,